Redx Pharma Plc

Redx Pharma Plcverified

REDX.L

Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom. It discovers and develops small molecule drugs for treating anti-cancer and fibrosis targets in the areas of unmet medical needs. The company also develops RXC004, a porcupine inhibitor that is in Phase II clinical trial for targeted therapy of Wnt-ligand driven cancer; and RXC007, an oral selective rho associated coiled-coil containing protein kinase 2 (ROCK2) inhibitor for the treatment of fibrotic diseases. In addition, it develops gastrointestinal targeted ROCK inhibitor to treat crohn's disease-associated fibrosis; discoidin domain receptors (DDRs) inhibitor for the treat...[Read more]

Industry

Biotechnology

IPO Date

2015-03-27

Stock Exchange

LSE

Ticker

REDX.L

The Enterprise Value as of December 2025 (TTM) for Redx Pharma Plc (REDX.L) is 57.94M

According to Redx Pharma Plc’s latest financial reports and current stock price. The company's current Enterprise Value is 57.94M. This represents a change of -54.68% compared to the average of 127.85M of the last 4 quarters.

Redx Pharma Plc (REDX.L) Historical Enterprise Value (quarterly & annually)

How has REDX.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Redx Pharma Plc over the last ten years is 68.75M. The current 57.94M Enterprise Value has changed 8.33% with respect to the historical average. Over the past ten years (40 quarters), REDX.L's Enterprise Value was at its highest in in the September 2021 quarter at 223.21M. The Enterprise Value was at its lowest in in the March 2018 quarter at -5260083.44.

Quarterly (TTM)
Annual

Average

68.75M

Median

52.96M

Minimum

4.54M

Maximum

207.09M

Redx Pharma Plc (REDX.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Redx Pharma Plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.19%

Maximum Annual Enterprise Value = 207.09M

Minimum Annual Increase = -70.86%

Minimum Annual Enterprise Value = 4.54M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202386.67M-33.67%
2022130.66M-36.91%
2021207.09M132.60%
202089.03M1.19%
20196.89M51.80%
20184.54M-64.52%
201712.79M-70.86%
201643.88M-14.00%
201551.02M-7.06%
201454.90M-3.28%

Redx Pharma Plc (REDX.L) Average Enterprise Value

How has REDX.L Enterprise Value performed in the past?

The current Enterprise Value of Redx Pharma Plc (REDX.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

141.47M

5-year avg

104.07M

10-year avg

68.75M

Redx Pharma Plc (REDX.L) Enterprise Value vs. Peers

How is REDX.L’s Enterprise Value compared to its peers?

Redx Pharma Plc’s Enterprise Value is greater than E-therapeutics Plc (36.43M), less than OKYO Pharma Limited (76.67M), greater than Midatech Pharma plc (-1306327.30), greater than C4X Discovery Holdings plc (26.47M), greater than Synairgen plc (1.06M), greater than Theracryf Plc (2.40M), greater than BiVictriX Therapeutics Plc (5.24M), greater than Intelligent Ultrasound Group plc (40.28M), greater than Destiny Pharma plc (-3509485.00), greater than ReNeuron Group plc (-5684963.82),

Build a custom stock screener for Redx Pharma Plc (REDX.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Redx Pharma Plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Redx Pharma Plc (REDX.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Redx Pharma Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Redx Pharma Plc's Enterprise Value?

What is the highest Enterprise Value for Redx Pharma Plc (REDX.L)?

What is the 3-year average Enterprise Value for Redx Pharma Plc (REDX.L)?

What is the 5-year average Enterprise Value for Redx Pharma Plc (REDX.L)?

How does the current Enterprise Value for Redx Pharma Plc (REDX.L) compare to its historical average?